In Vivo interactions of aluminum with hepatic cytochrome P-450 and metallothionein

Toxicological Sciences

Volumn 8, Issue 4, 1987, Pages 541-548

  Jeffery, E H ^a   Jansen, H T ^a   Dellinger, J A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ANIMAL; CYTOCHROME P-450 ENZYME SYSTEM; CYTOSOL; KIDNEY; LIPID PEROXIDES; LIVER; MALE; METALLOTHIONEIN; METALS; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; RATS; RATS, INBRED STRAINS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 77957183653     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/8.4.541     Document Type: Article

References (46)

1. ALFREY, A. C. (1986). Dialysis encephalopathy. Kidney Int. 29(Suppl. 18), S53-S57.
2. ALFREY, A. C., HEGG, a., AND CRASWELL, P. (1980). Metabolism and toxicity of aluminum in renal failure. J. Clin. Nulr. 33, 1509.
3. ALFREY, A. C., SEDMAN, A., AND CHAN, Y.-L. (1985). The compartmentalization and metabolism of aluminum in uremic rats. J. Lab. Clin. Med. 105, 227-233.
4. ASAOKA, K., AND TAKAHASHI, K. J. (1981). Enzymatic assay of reduced glutathione aryltransferase with O-di-nitrobenzene as a substrate. J. Biochem. 90, 1237-1242.
5. BIDLACK, W. R., BROWN, R. C., MARK, M. P., MESKJN, M. S., LEE, T. C., AND KLEIN, G. L. (1987). Effect of aluminum on the hepatic mixed function oxidase and drug metabolism. Drug Nutr. Interact., 5, 33-42.
6. BIDLACK, W. R., BROWN, R. C., MESKJN, M. S., LEE, T. C., AND KLEIN, G. L. (1986). Effect of aluminum on hepatic mixed function oxidase activity and glucur-onidation. Fed. Proc. 45, 975.
7. CHERIAN, M. G., GOYER, R. A., AND DELAQUERRIERE-RICHARDSON, L. (1976). Relationship between plasma cadmium-thionein and cadmium-induced nephropathy. Toxicol. Appl. Pharmacol. 41, 145-146.
8. CHMIELNICKA, J., BEM, E. M., BRZEZNICKA, E. A., AND KASPEREK, M. (1985). The tissue disposition of zinc and copper following repeated administration of cadmium and selenium to rats. Environ. Res. 37, 419-424.
9. CRAPPER, D. R., AND DALTON, A. J. (1973). Aluminum induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention. Physiol. Behav. 10, 935-945.
10. DUVAL, G., GOERING, P. L., AND FOWLER, B. A. (1986). Hydrophobic interaction chromatography of rat kidney lead-binding protein (PbBP) and metallothionein. Toxicologist 6, 101.
11. ERNSTER, L., AND NORDENBRAND, L. (1967). In Methods in Enzymology (R. W. Estabrook and M. E. Pullman, Eds.), Vol. 10, p. 574. Academic Press, New York.
12. GOODMAN, W. G. (1986). Experimental aluminum-induced bone disease: Studies in vivo. Kidney Int. 29(Suppl. 18), S32-S35.
13. GORSKY, J. E" DIETZ, A. A., SPENCER, H., AND OSIS, D. (1979). Metabolic balance of aluminum studied in six men. Clin. Chem. 25, 1739-1743.
14. GOYER, R. A. (1983). Metal-protein complexes in detoxification processes. In Chemical Toxicology and Clinical Chemistry of Metals (S. S. Brown and J. Savory, Eds.), pp. 199-209. Academic Press, New York.
15. GUTTERIDGE, J. M., QUINLAN, G. J., CLARK, I., AND HALLIWELL, B. (1985). Aluminum salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochem. Biophys. Acta 835, 441-447.
16. HEAF, J. G., PODENPHANT, J., AND ANDERSEN, J. R. (1986). Bone aluminium deposition in maintenance dialysis patients treated with aluminium-free dialy-sate: Role of aluminium hydroxide consumption. Nephron 42, 210-216.
17. JEFFERY, E. (1983). The effect of zinc on NADPH oxidation and monooxygenase activity in rat hepatic micro-somes. Mol. Pharmacol. 23, 467-473.
18. KAEHNY, W. D., HEGG, A. P., AND ALFREY, A. C. (1977). Gastrointestinal absorption of aluminum-containing antacids. N. Engl. J. Med. 296, 1389-1390.
19. KJNG, S. W., SAVORY, J., AND WILLS, M. R. (1982). Aluminium distribution in serum following hemodialysis. J. CHn. Lab. Sci. 12, 143-149.
20. KLATZO, I., WISNIEWSKI, H., AND STREICHER, E. (1965). Experimental production of neurofibrillary degeneration. I. Light microscopic observations. J. Neu-ropathol. Exp. Neurol. 24, 187-199.
21. KLEIN, G. L., BERGQUIST, W. E., AMENT, M. E., CoBURN, J. W., MILLER, N. L., AND ALFREY, A. C. (1984). Hepatic aluminum accumulation in children on total parenteral nutrition. J. Pediatr. Gastroenterol. Nutr. 3, 740-743.
22. KOGEORGOS, J., AND SCHOLTZ, C. (1982). Neurofibrillary tangles in aluminium encephalopathy: A new finding. Brit. Neuropath. Soc. Proc. 38, 246.
23. KOVALCHIK, M. T., KAEHNY, W. D., JAACKSON, T., AND ALFREY, A. C. (1978). Aluminum kinetics during hemodialysis. J. Lab. Clin. Med. 92, 712-716.
24. KUWAHARA, S., AND MANNERING, G. J. (1985). Evidence for a predominantly NADH-dependent O-deal-kylating system in rat hepatic microsomes. Biochem. Pharmacol. 34, 4215-4228.
25. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L., AND RANDALL, R. J. (1951). Protein measurement with the folin-phenol reagent. J. Biol. Chem. 193, 265-275.
26. MAINS, M. D., AND KAPPAS, A. (1976). Induction of hepatic heme oxygenase by metals. In Porphyrins in Human Diseases (M. Doss, Ed.), pp. 43-52. Kaiser, Basel.
27. MASUDA, Y., AND MURANO, T. (1977). Carbon tetrachloride-induced lipid peroxidation of rat liver microsomes in vitro. Biochem. Pharmacol. 26, 2275-2282.
28. MCGONIGLE, R. J. S., AND PARSONS, V. (1985). Aluminium-induced anaemia in haemodialysis patients. Nephron 39, 1-9.
29. MCVETY, K. J., AND SHAIKH, Z. A. (1986). Gold-induced changes in copper, zinc and metallothionein. Toxicologist 6, 264.
30. MOGILNICKA, E. M., AND PIOTROWSKI, J. K. (1977). Binding of gold in the kidney of the rat. Biochem. Pharmacol. 26, 1819-1820.
31. NASH, T. (1953). The colorimetric estimation of formaldehyde by means of the Hantzch reaction. Biochem. J. 55, 416-421.
32. OMURA, T., AND SATO, R. (1964). The carbon monoxide-binding pigment ofliver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378.
33. ONOSAKA, S., TANAKA, K., AND CHERIAN, M. G. (1984). Effects of cadmium and zinc on tissue levels of metallothionein. Environ. Health Perspect. 54, 67-72.
34. PETERING, H. G. (1978). Some observations on the interaction of zinc, copper, and iron metabolism in lead and cadmium toxicity. Environ. Health Perspect. 25, 141-145.
35. RAFTER, G. W. (1981). Copper inhibition of glutathione reductase and its reversal with gold thiolates, thiol, and disulfide compounds. Biochem. Med. 27, 381-391.
36. SCHNELL, R. C., AND PENCE, D. H. (1981). Differential effects of cadmium on the hepatic microsomal cytochrome P-A50 system in male and female rats. Toxicol. Lett. 9, 19-25.
37. SEBERT, J. L., FOURNIER, A., LEFLON, P., FOHRER, P., DE FREMONT, J. F., MORINIERE, PH., GALY, CL., MARIE, A., DEMONTIS, R., BOUDAILLIEZ, B., GUERIS, J., DKHISSI, H., GARABEDIAN, M., AND LAMBREY, G. (1986). Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hémofiltration. Nephron 42, 34-40.
38. SEDMAN, A. B., KLEIN, G. L., MERRITT, R. J., MILLER, M. S., WEBER, K. O., GILL, W. L" ANAND, H., AND ALFREY, A. C. (1985). Evidence of aluminum loading in infants receiving intravenous therapy. N. Engl. J. Med. 312, 1337-1343.
39. SHIGEMATSU, H., YAMAHO, S., AND YOSHIMURA, H. (1976). NADH-dependent O-deethylation of p-nitro-phenetole with rabbit liver microsomes. Arch. Biochem. Biophys. 173, 178-186.
40. SLADEK, N. E., AND MANNERING, G. J. (1969). Induction of drug metabolism. 1. Differences in the mechanisms by which polycyclic hydrocarbons and phénobarbital produce their inductive effects on microsomal N-demethylation systems. Mol. Pharmacol. 5, 174-185.
41. SLANINA, P., FRECH, W., BERNHARDSON, A., CEDER-GREN, A., AND MATTSSON, P. (1985). Influence of dietary factors on aluminium absorption and retention in the brain and bone of rats. Acta Pharmacol. Toxicol. 56, 336-341.
42. TRAPP, G. A. (1983). Plasma aluminum is bound to transferrin. Life Sci. 33, 311-316.
43. WAALKES, M. P., HARVEY, M. J., AND KLAASEN, C. D. (1984). Relative in vitro affinity of hepatic metallothionein for metals. Toxicol. Lett. 20, 33-39.
44. WARD, M. K., FEEST, T. G., ELLIS, H. A., PARKINSON, I. S., AND KERR, D. N. S. (1978). Osteomalacia and dialysis osteodystrophy: Evidence for a waterborne etiological agent, probably aluminum. Lancet 1, 841-845.
45. WISNIEWSKI, H., AND TERRY, R. D. (1970). An experimental approach to the morphogenesis of neurofibrillary degeneration and the argyrophilic plaque. In Ciba Foundation Symposium on Alzheimer’s Disease and Related Conditions (G. E. W. Wolstenholme and M. O’Connor, Eds.), pp. 223-248. Churchill.
46. YOSHIDA, T., SUZUKI, Y., AND HASHIMOTO, Y. (1979). Sex-related effect of cadmium on hepatic cytochrome P-450, drug-metabolizing enzymes and ¿-aminolevulinic acid synthetase and heme oxygenase in the rat. Toxicol. Lett. 4, 97-102.